Collectively, as illustrated in Figure 7, the hepatoprotective effects of FA and underlying complicated mechanisms by which FA activates AMPK are emphasized and vital evidence inspiring the development of FA-based innovative drug candidates for the treatment of liver fibrosis and related complications is provided. Here, PRKAA1 is linked to Hepatic fibrosis.